Long-term treatment of adult ADHD in a naturalistic setting: Clinical predictors of attrition, medication choice, improvement, and response-Reference-Cited by-同舟云学术

Long-term treatment of adult ADHD in a naturalistic setting: Clinical predictors of attrition, medication choice, improvement, and response

Published:2023-04-28 Issue:6 Volume:24 Page:523-538
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Brancati Giulio Emilio¹^ORCID,De Dominicis Francesco²,Petrucci Alessandra¹,Pallucchini Alessandro³,Carli Marco⁴,Medda Pierpaolo⁵,Schiavi Elisa⁵,De Rossi Pietro⁶,Vicari Stefano⁶,Perugi Giulio¹^ORCID

Affiliation:

1. Psychiatry Unit 2, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

2. Mental Health Centre, Local Health Unit n. 2, Spoleto, Italy

3. Addiction Treatment Centre, Local Health Unit, Carrara, Italy

4. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

5. Psychiatry Unit 2, Azienda Ospedaliero‐Universitaria Pisana, Pisa, Italy

6. Department of Neuroscience, Child and Adolescence Neuropsychiatry Unit, I.R.C.C.S. Bambino Gesù Children’s Hospital, Rome, Italy

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

https://www.tandfonline.com/doi/pdf/10.1080/15622975.2023.2168750

Reference82 articles.

1. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder

2. Long-Term Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

3. Long-Term Effectiveness and Safety of Dexmethylphenidate Extended-Release Capsules in Adult ADHD

4. Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder

5. Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD